Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Etoricoxib impurity 2 is a characterized impurity of the non-steroidal anti-inflammatory drug Etoricoxib, primarily known for its selective inhibition of cyclooxygenase-2 (COX-2). This impurity is important for analytical studies and quality control in pharmaceutical applications, particularly in the assessment of Etoricoxib purity and stability. Research involving this compound contributes to understanding the implications of impurities on drug efficacy and safety profiles. -
Drug Impurity
Duloxetine impurity 5 oxalate is a byproduct of Duloxetine oxalate, specifically the N-methyl (R)-isomer. This compound serves as a critical reference standard for quality control and analytical characterization in pharmaceutical research. Its identification and quantification are essential for ensuring the purity and safety of Duloxetine formulations in drug development studies. -
Drug Impurity
Fluticasone impurity 7, an impurity of Fluticasone, primarily affects steroidal pathways. Its biological activity can provide insights into the degradation and stability of Fluticasone formulations. This compound is essential for analytical research in quality control and regulatory assessments related to pharmaceuticals. -
Drug Impurity
rel-(R,R)-Glycopyrrolate is a drug impurity characterized by its structural configuration as a glycopyrrolate analogue. It is primarily utilized in research to study the pharmacological effects of glycopyrrolate and its related compounds. This reagent is important for understanding impurities in pharmaceutical formulations, which can influence drug efficacy and safety profiles. -
Drug Impurity
Solifenacin impurity 3, also known as Solifenacin impurity D, is a specific impurity associated with Solifenacin. It is essential for quality control and validation in pharmaceutical formulations involving Solifenacin. This impurity serves as an important reference standard for analytical chemistry applications, ensuring the purity and integrity of Solifenacin-based drug products. -
Drug Impurity
Parecoxib sodium impurity 10 is a defined impurity associated with Parecoxib sodium. As a potential drug impurity, it is relevant for pharmacological studies and quality control in the development of non-steroidal anti-inflammatory drugs (NSAIDs). Researchers studying the stability and safety of Parecoxib formulations may find this compound useful for analytical purposes and impurity profiling. -
Drug Impurity
Rivaroxaban impurity 10 is a drug impurity associated with the anticoagulant Rivaroxaban. This compound is essential for quality control and stability testing during pharmaceutical development and manufacturing processes. It may also be used for research purposes to study the metabolic pathways and degradation products of Rivaroxaban, ensuring the integrity and safety of the final pharmaceutical product. -
Drug Impurity
Rifampicin impurity 3 is a chemical impurity associated with the antibiotic Rifampicin. It serves as an important reference standard in the analysis of drug purity and quality control. This compound is utilized in pharmacological research to study the degradation products and stability of Rifampicin, contributing to the understanding of its overall efficacy and safety profile. -
Drug Impurity
Metformin impurity 11, also known as Metformin impurity E, is a known impurity associated with Metformin. This compound is critical for researchers involved in the analysis of drug purity and quality control in pharmaceutical development. Its identification and characterization are important for ensuring the safety and efficacy of Metformin and related formulations. -
Drug Impurity
Pramipexole impurity 1 (2-N-Propyl pramipexole) is a chemical impurity associated with the drug Pramipexole, which targets dopamine receptors. This impurity is essential for quality control and validation studies in pharmaceutical research, ensuring the purity and safety of drug formulations. It serves as a reference compound in analytical chemistry and can facilitate the investigation of drug metabolism and pharmacokinetics. -
Drug Impurity
Escitalopram Impurity 1 is a known impurity linked to the selective serotonin reuptake inhibitor (SSRI) escitalopram. This compound is essential for evaluating the purity and quality of escitalopram in pharmaceutical formulations. Its analysis aids in understanding potential side effects and therapeutic efficacy in drug development and quality control processes. -
Drug Impurity
Itraconazole impurity 13 is a specified impurity derived from Itraconazole. This compound may be relevant for the assessment of drug quality and stability, particularly in pharmaceutical formulations. It is utilized in the characterization of Itraconazole products and can aid in ensuring compliance with regulatory standards during drug development and manufacturing processes. -
Drug Impurity
Itraconazole impurity 9, also known as isopropyl Itraconazole, is a compound associated with the antifungal agent Itraconazole. It serves as a drug impurity that may arise during the synthesis or formulation of Itraconazole. This compound is useful for research applications focused on assessing the purity and stability of pharmaceutical formulations. Its presence can impact the pharmacological properties and safety profile of Itraconazole, making it significant for quality control in drug development. -
Drug Impurity
Aripiprazole impurity 22 is a validated impurity associated with the antipsychotic agent Aripiprazole. This compound is crucial for quality control and method development in pharmacological studies. Its characterization is essential for assessing the purity and safety of Aripiprazole formulations, thereby supporting regulatory compliance in drug development and analytical research. -
Drug Impurity
Alfuzosin EP impurity 6 is a known impurity associated with the pharmaceutical compound Alfuzosin EP. It serves as a reference standard for quality control and analytical studies, particularly in the evaluation of drug purity and compliance with pharmacopoeial specifications. Its presence is critical for assessing the overall safety and efficacy profile of Alfuzosin formulations during drug development and regulatory processes. -
Drug Intermediate Control
BI SF3 hydrochloride is a synthetic intermediate primarily used in the synthesis of quinolinyloxazoles, which demonstrate kallikrein inhibitory activity. Its role in facilitating the production of these compounds makes it valuable for research into potential therapeutic agents targeting kallikrein-related pathways. -
Drug Impurity
Omeprazole impurity 5 is a known impurity associated with the proton pump inhibitor Omeprazole. This chemical reagent is essential for analytical research, particularly in the development and quality control of pharmaceutical formulations. Its presence can affect drug stability and efficacy, making it important for studies focusing on drug metabolism and impurity profiles. -
Drug Impurity
Apixaban impurity 27 is a known impurity of the anticoagulant Apixaban, primarily used for pharmacokinetic and toxicological studies. This compound serves as an essential reference standard for evaluating the purity and quality of Apixaban formulations. It plays a critical role in ensuring compliance with regulatory standards in drug development and quality control processes. -
Drug Impurity
Febuxostat impurity 1 is a chemical impurity associated with the synthesis of Febuxostat, a selective xanthine oxidase inhibitor. This compound serves as a critical standard for analytical development, helping to ensure the quality and consistency of Febuxostat formulations. Researchers can utilize Febuxostat impurity 1 for various applications in stability testing and method validation in pharmaceutical research and development. -
Drug Impurity
Paliperidone impurity 3 hydrochloride is a known impurity of the antipsychotic agent Paliperidone hydrochloride. This compound is valuable for quality control and analytical research to ensure the safety and efficacy of pharmaceutical formulations. Its characterization supports the development of standardized methods for assessing drug purity in pharmaceutical applications. -
Drug Impurity
Dacomitinib impurity 4 is an identified impurity of the targeted cancer therapy Dacomitinib, which functions as a pan-ERBB inhibitor. This reagent is essential for researchers studying the purity and stability of Dacomitinib formulations and supports the evaluation of drug quality in pharmaceutical development. Its analysis contributes to understanding the safety and efficacy of ERBB-targeted therapies in cancer research. -
Drug Impurity
Rosuvastatin impurity 35, also known as Rosuvastatin acid allyl ester, is a chemical impurity associated with the cholesterol-lowering agent Rosuvastatin. This compound serves as an important reference standard for drug quality control and analytical studies, facilitating the assessment of synthetic processes and product purity. It can be utilized in research applications focused on the pharmacokinetics and pharmacodynamics of Rosuvastatin and its derivatives. -
Drug Impurity
Levetiracetam impurity 8 is a characterized impurity of the antiepileptic drug Levetiracetam. It is utilized in analytical and quality control applications within pharmaceutical research to ensure the purity and stability of Levetiracetam formulations. This compound supports the investigation of drug metabolism and assists in the assessment of potential impacts on safety and efficacy profiles. -
Drug Impurity
Aripiprazole impurity 37 is a known impurity associated with the antipsychotic drug Aripiprazole. This compound is critical for analytical assessments, including stability studies and impurity profiling. It serves as a quality control standard in the pharmaceutical industry to ensure the purity and safety of Aripiprazole formulations. Researchers can utilize Aripiprazole impurity 37 for method development and validation in drug characterization. -
Drug Impurity
Acetaminophen Impurity 1 is a recognized impurity of the analgesic compound acetaminophen. This reagent serves as a critical control substance for the analysis and quality assurance of acetaminophen formulations. It is crucial for researchers investigating drug stability, degradation pathways, and the safety profile of acetaminophen-based therapeutics. -
Drug Impurity
Duloxetine impurity 1 is a characterized impurity associated with Duloxetine, a serotonin-norepinephrine reuptake inhibitor. This compound serves as an important reference standard in the pharmaceutical development and quality control of Duloxetine formulations. Its analysis is critical for ensuring the purity and safety of drug products containing this active pharmaceutical ingredient. Research applications include method validation and stability testing in pharmaceutical sciences. -
Drug Impurity
Fluocinolone impurity 3 is a chemical impurity associated with the corticosteroid fluocinolone. It serves as an important reference standard in quality control and analytical studies to assess the purity and identify the composition of fluocinolone formulations. This compound can be utilized in pharmacokinetic studies and stability testing, contributing to the evaluation of drug safety and efficacy in pharmaceutical development. -
Drug Impurity
Atenolol impurity 3 is a chemical impurity associated with the β-adrenergic antagonist Atenolol. It serves as an important reference standard for quality control and analytical testing in pharmaceutical research. This impurity can be utilized to assess the purity profile of Atenolol formulations and support regulatory compliance in drug development. -
Drug Impurity
Rivastigmine impurity 11 is a known impurity of Rivastigmine, a reversible inhibitor of acetylcholinesterase. This compound is of significant interest for quality control and toxicological studies in pharmaceutical research. Its analysis is crucial for ensuring the purity and safety of Rivastigmine formulations, supporting compliance with regulatory standards in drug development. -
Drug Impurity
Aglutin impurity 7 is a chemical impurity associated with Aglutin. As a drug impurity, it is essential for analytical and quality control processes in pharmaceutical research. Characterizing this impurity is vital for ensuring the safety and efficacy of Aglutin-based formulations. Its identification and quantification contribute to regulatory compliance and product development. -
Drug Impurity
Corey lactone benzoate impurity 1 is a known impurity of Corey lactone benzoate, functioning primarily as a chemical reference standard in pharmacological research. It serves as a critical tool in drug formulation studies and quality control processes, helping to evaluate the purity and stability of Corey lactone derivatives. Its presence can significantly influence the biological activity and safety of formulations, making it essential for thorough analytical characterization in drug development. -
Drug Impurity
Telmisartan Impurity 9 is a structural impurity related to the antihypertensive agent Telmisartan. This compound is utilized primarily in the assessment of drug purity and quality control during the synthesis of Telmisartan. Its characterization is critical for regulatory compliance and ensures the safety and efficacy of the final pharmaceutical product. -
Drug Impurity
Simvastatin impurity 11 is a byproduct of Simvastatin synthesis. This reagent is utilized in drug quality control and analytical testing to ensure the purity and safety of Simvastatin formulations. Its presence in pharmaceutical preparations can impact efficacy and safety, making it essential for monitoring in drug development and regulatory compliance. -
Drug Impurity
Cetirizine impurity 8, also known as Deschloro cetirizine, is a known impurity of the antihistamine Cetirizine. This compound is significant for analytical chemistry and quality control applications, particularly in the assessment of drug purity and stability. Its presence can influence the pharmacological profile of cetirizine and is crucial for regulatory compliance in pharmaceutical development. -
Drug Impurity
Prilocaine impurity 1 is a noted impurity associated with Prilocaine, a local anesthetic agent. This compound serves as an important reference standard for quality control and analytical applications in pharmaceutical research. Its characterization is essential for ensuring the purity and safety of pharmacological formulations containing Prilocaine. -
Drug Impurity
Simvastatin impurity 2 sodium is a known impurity of the cholesterol-lowering agent Simvastatin sodium. It is primarily utilized in the pharmaceutical industry for quality control and analytical purposes, ensuring the purity and efficacy of Simvastatin formulations. Research involving this impurity can aid in understanding its effects on drug safety and pharmacological profiles. -
Drug Intermediate
Gilvocarcin V intermediate-1 is a key drug intermediate involved in the biosynthesis of Gilvocarcin V. This compound plays a significant role in the production of this potent antitumor agent, which demonstrates notable biological activity against various cancer cell lines. Researchers can utilize this intermediate for studying the metabolic pathways of Gilvocarcin V synthesis and its potential therapeutic applications in oncology. -
Drug Impurity
Donepezil impurity 11 hydrochloride is a known impurity associated with Donepezil hydrochloride, which is used in the treatment of Alzheimer's disease. This compound can be utilized in the analysis of pharmaceutical formulations and quality control, ensuring the integrity and safety of Donepezil-containing products. Its presence and concentration are critical for regulatory compliance and characterization studies in drug development. -
Drug Impurity
Adrenaline impurity 3 is a known impurity derived from adrenaline, primarily identified in pharmaceutical formulations. Its presence can influence the stability and efficacy of adrenaline-based drugs. Research applications include the study of drug impurities and their effects on pharmacological properties, assisting in quality control and safety assessments of adrenaline formulations. -
Drug Impurity
Chlorthalidone impurity 9 is a known impurity associated with chlorthalidone. It serves as a reference standard for analytical studies aiming to assess the purity of chlorthalidone formulations. This compound is critical in drug development and quality control processes, where monitoring impurities is essential for ensuring the safety and efficacy of pharmaceutical products. It is particularly relevant in pharmacological research and regulatory assessments of thiazide diuretics. -
Drug Impurity
Prasugrel impurity 10 is a known impurity associated with the antiplatelet drug Prasugrel. This compound is used to assess the purity of Prasugrel formulations and is relevant in pharmacokinetic and toxicological studies. The identification and quantification of drug impurities are critical for regulatory compliance and ensuring the safety and efficacy of pharmaceutical products. -
Drug Impurity
Ranolazine impurity 5 is a chemical impurity associated with Ranolazine, a drug commonly used for the treatment of chronic angina. This impurity can be utilized in the analysis of drug purity, stability studies, and the assessment of manufacturing processes. Its presence in formulations may impact the pharmacological profile and safety of Ranolazine, making it essential for quality control and regulatory compliance in pharmaceutical research. -
Drug Impurity
Beclometasone dipropionate impurity 8 is a recognized impurity of the corticosteroid beclometasone dipropionate. This compound is essential for the analysis and characterization of pharmaceutical formulations, particularly in quality control and compliance settings. Its presence may influence the efficacy and safety profile of the drug, making it significant for ongoing research in drug development and formulation studies. -
Drug Impurity
Abiraterone impurity 2 is a known impurity associated with Abiraterone, a selective inhibitor of androgen biosynthesis. This compound is crucial for pharmacokinetic studies and helps in understanding the metabolic profile of Abiraterone. It is primarily utilized in research applications focused on drug quality control and stability testing in pharmaceutical development. -
Drug Impurity
Mirabegron impurity 4 hydrochloride is a chemical impurity associated with Mirabegron hydrochloride, a β3-adrenergic agonist. This impurity is crucial for quality control in drug development, ensuring the purity and safety of pharmaceutical formulations. Research utilizes Mirabegron impurity 4 hydrochloride to assess its impact on pharmacokinetics and pharmacodynamics in the context of therapeutic applications targeting overactive bladder conditions. -
Drug Impurity
Olmesartan impurity 16 is a derivative of the antihypertensive agent Olmesartan, identified as a drug impurity. It serves as an important reference standard for analytical and quality control applications in pharmaceutical research and development. This impurity can be utilized to assess the purity and stability of Olmesartan formulations, ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Simvastatin impurity 8 is a known impurity associated with the cholesterol-lowering agent Simvastatin. This compound is primarily utilized for quality control and analytical applications in pharmaceutical research, ensuring the purity and efficacy of Simvastatin formulations. The identification and quantification of impurities like Simvastatin impurity 8 are critical for maintaining compliance with regulatory standards in drug development and manufacturing. -
Drug Impurity
Ropinirole impurity 13 is a drug impurity associated with the compound Ropinirole, primarily recognized for its role in dopaminergic signaling pathways. This impurity is relevant for quality control and analytical research, particularly in the development and stability assessment of Ropinirole formulations. Its characterization is essential for ensuring the purity and efficacy of pharmaceutical products containing Ropinirole. -
Drug Impurity
Beclometasone dipropionate impurity 4, also known as 2-Bromo beclomethasone dipropionate, is a characterized impurity of beclometasone dipropionate. This compound is primarily relevant in the assessment of drug quality and stability in pharmaceutical formulations. It serves as a critical component in analytical studies aimed at ensuring the purity and efficacy of corticosteroid medications. Its identification and quantification are essential for regulatory compliance and quality control in drug development processes. -
Drug Intermediate
6-Hydroxygenistein is an isoflavonoid compound that serves as a critical intermediate in the synthesis of various methylated isoflavonoids. Isolated from Baptisia hirsuta, this compound plays a significant role in the production of bioactive isoflavonoid derivatives, which are valuable in pharmacological research. Its utility in organic synthesis contributes to advancing studies in medicinal chemistry and natural product research.
